Royalty Pharma plc
Royalty Pharma acquires biopharmaceutical royalties and funds innovation across the industry.
10-QNov 13Latest SEC filing
Nov 2Latest story
November 2026
August 2026
Royalty Pharma acquires biopharmaceutical royalties and funds innovation across the industry.